Cancer Biology & Medicine

Article	Citations
Mitochondrial transplantation sensitizes chemotherapy to inhibit tumor development by enhancing anti-tumor immunity	197
Eliminating cervical cancer: a global health imperative for women	107
Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up	67
Early-onset gastric cancer global burden profile, trends, and contributors	60
Unraveling vascular mechanisms in melanoma: roles of angiogenesis and vasculogenic mimicry in tumor progression and therapeutic resistance	54
Immunotherapy rechallenge of patients with advanced NSCLC progression after sequential treatment with third-generation EGFR-TKI and immunotherapy	49
The Warburg effect drives dedifferentiation through epigenetic reprogramming	45
Stability and variability of molecular subtypes: comparative analysis of primary and metastatic triple-negative breast cancer	45
Optimizing the cancer research landscape for the benefit of patients and society: A strategic perspective of the German Cancer Research Center (DKFZ) and its partnerships with university medical cente	45
Role of the tumor microenvironment in shaping IDH-wildtype glioma plasticity, and potential therapeutic strategies	43
ENO1 expression and Erk phosphorylation in PDAC and their effects on tumor cell apoptosis in a hypoxic microenvironment	40
PD-1 inhibitors provide new opportunities in conversion therapy for stage IV gastric cancer	38
Biological mechanism and immune response of MHC-II expression in tumor cells	37
Associations between polymorphisms in leptin and leptin receptor genes and colorectal cancer survival	35
Chinese Society of Clinical Oncology Non-small Cell Lung Cancer (CSCO NSCLC) guidelines in 2024: key update on the management of early and locally advanced NSCLC	32
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis	28
Cancer stem cells: a target for overcoming therapeutic resistance and relapse	27
Cancer-derived exosomal circTMEM56 enhances the efficacy of HCC radiotherapy through the miR-136-5p/STING axis	27
Immune checkpoint inhibitors: breakthroughs in cancer treatment	26
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity	25
Advances in lung cancer screening and early detection	25
Cancer cell-derived migrasomes harboring ATF6 promote breast cancer brain metastasis via endoplasmic reticulum stress-mediated disruption of the blood-brain barrier	24
Effects of Helicobacter pylori eradication on the profiles of blood metabolites and their associations with the progression of gastric lesions: a	22
Human papillomavirus vaccination willingness under resource inequities: momentary intervention effects of an educational video	22
Nodal peripheral T-cell lymphomas in the new classification systems	22

Progress toward cervical cancer elimination: global disparities and China’s contributions	21
Glofitamab vs. real-world regimens in Chinese patients with third- or later-line relapsed/refractory diffuse large B-cell lymphoma: an external control study	20
Facing challenges with hope: universal immune cells for hematologic malignancies	20
Enhancing cancer immunotherapy through polymer-based antibody conjugation technologies	19
Intricate roles of estrogen and estrogen receptors in digestive system cancers: a systematic review	19
Conceptualizing the complexity of ferroptosis to treat triple-negative breast cancer: theory-to-practice	18
Biological insights in non-small cell lung cancer	18
Elucidating the synergistic roles of CD4+ T and dendritic cells in antitumor immunity	17
PD-1 and LAG-3 dual blockade: emerging mechanisms and potential therapeutic prospects in cancer	17
Ubiquitination in osteosarcoma: unveiling the impact on cell biology and therapeutic strategies	17
First-line immunotherapy for advanced non-small cell lung cancer: current progress and future prospects	17
Current treatment paradigm and survival outcomes among patients with newly diagnosed multiple myeloma in China: a retrospective multicenter study	17
Advances in antibody-drug conjugates for urothelial carcinoma treatment	17
Perspective on novel proteins encoded by circular RNAs in glioblastoma	16
Alterations in DNA damage response and repair genes as potential biomarkers for immune checkpoint blockade in gastrointestinal cancer	16
Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma	15
Neutrophils as key regulators of tumor immunity that restrict immune checkpoint blockade in liver cancer	15
Current and future trends in whole genome sequencing in cancer	14
A quick and reliable image-based AI algorithm for evaluating cellular senescence of gastric organoids	14
Deep proteome profiling promotes whole proteome characterization and drug discovery for esophageal squamous cell carcinoma	14
From dichotomy to diversity: deciphering the multifaceted roles of tumor-associated macrophages in cancer progression and therapy	13
Research progress in tumor angiogenesis and drug resistance in breast cancer	13
Immunological and metabolic optimization of tumor neoantigen vaccines	13
CAR T-cell therapy for relapsed/refractory CD5-positive diffuse large B-cell lymphoma yields more favorable outcomes than standard therapy	13
Chromatin relaxation dynamics and histone PTMs in the early DNA damage response	13
Liquid-liquid phase separation in DNA double-strand break repair	13
PYK2 mediates the BRAF inhibitor (vermurafenib)-induced invadopodia formation and metastasis in melanomas	12
Major roles of the circadian clock in cancer	11
Anti-tumor pharmacology of natural products targeting mitosis	11
BLM helicase inhibition synergizes with PARP inhibition to improve the radiosensitivity of olaparib resistant non-small cell lung cancer cells by inhibi	11
Loss of NEIL3 activates radiotherapy resistance in the progression of prostate cancer	11
A causal variant rs3769823 in 2q33.1 involved in apoptosis pathway leading to a decreased risk of non-small cell lung cancer	11
The role of intestinal flora on tumorigenesis, progression, and the efficacy of PD-1/PD-L1 antibodies in colorectal cancer	11
Treatment strategies for patients with HER2-positive gastric cancer	11
Chidamide suppresses macrophage-mediated immune evasion and tumor progression in small cell lung cancer by targeting the STAT4/CCL2 signaling pathway	10
Single-arm trials for domestic oncology drug approvals in China	10
Early detection of gastric cancer in China: progress and opportunities	10
Current status of management of immune-related adverse events and practical needs for oncologist education	10
Next-generation antibody–drug conjugates revolutionize the precise classification and treatment of HER2-expressing breast cancer	10
The evidence and concerns about screening ultrasound for breast cancer	10
Drug clinical trials on high-grade gliomas: challenges and hopes	10
Optimal immunotherapy duration in advanced NSCLC: defining the ideal treatment window	10
Effectiveness of postoperative adjuvant radiochemotherapy versus radiotherapy in thoracic esophageal squamous cell carcinoma with lymph node metastasis: a multicenter randomized study	9
Metabolic regulation of immune responses to cancer	9
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) guidelines in 2022: stratification and classification	9
Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer	9
Recent progress in targeting the sialylated glycan-SIGLEC axis in cancer immunotherapy	9
Cancer risk in relatives of BRCA1/2 pathogenic variant carriers in a large series of unselected patients with breast cancer	9
Potential treatment approaches for malignant peritoneal mesothelioma: in vivo and in vitro experimental study of natural killer cell immunotherapy	8
The HDAC inhibitor GCJ-490A suppresses c-Met expression through IKKα and overcomes gefitinib resistance in non-small cell lung cancer	8

Decoding the complexity of metastasis	8
Treatment strategies for advanced neuroendocrine neoplasms: current status and future prospects	8
MicroRNA-384 radiosensitizes human non-small cell lung cancer by impairing DNA damage response and repair signaling, which is inhibited by NF-κB	8
Understanding the mechanisms underlying obesity in remodeling the breast tumor immune microenvironment: from the perspective of inflammation	8
Epigenetic regulators as the foundation for molecular classification of colorectal cancer	8
Identifying occult high-risk features and stratified management strategies following curative resection for ampullary adenocarcinoma	8
N6-methyladenosine (m6A) RNA modification in tumor immunity	8
Modeling cervical cancer elimination: a pathway to inform policy decisions	8
Erratum to DYRK1A suppression restrains Mcl-1 expression and sensitizes NSCLC cells to Bcl-2 inhibitors	8
Development of glioblastoma organoids and their applications in personalized therapy	8
Azoximer bromide and hydroxyapatite: promising immune adjuvants in cancer	8
A therapeutic multi-epitope protein vaccine targeting HPV16 E6 E7 elicits potent tumor regression and cytotoxic immune responses	7
Large-scale loss-of-function perturbations reveal a comprehensive epigenetic regulatory network in breast cancer	7
The inducible secreting TLR5 agonist, CBLB502, enhances the anti-tumor activity of CAR133-NK92 cells in colorectal cancer	7
Mutations in Ras homolog family member A in patients with peripheral T-cell lymphoma and implications for personalized medicine	7
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells	7
Targeting PP2A for cancer therapeutic modulation	7
Erratum to Treatment strategies for patients with HER2-positive gastric cancer	7
Erianin inhibits the proliferation of lung cancer cells by suppressing mTOR activation and disrupting pyrimidine metabolism	7
Neoantigen cancer vaccines: a new star on the horizon	7
Senescent macrophages in cancer: roles in tumor progression and treatment opportunities	7
Therapeutic perspectives for adult soft tissue sarcoma—updates from the 2022 ASCO annual meeting	6
The evolution of cancer genomic medicine in Japan and the role of the National Cancer Center Japan	6
Harnessing the power of cancer-associated fibroblasts to revolutionize pancreatic cancer treatment	6
Angiogenesis in hepatocellular carcinoma: mechanisms and anti-angiogenic therapies	6
Chemotherapy-free radiotherapy combined with immune checkpoint inhibitors: a new regimen for locally advanced non-small cell lung cancer?	6
Integrated pretreatment stratification system for pancreatic cancer: combining anatomical resectability and tumor biological parameters	6
Extracellular vesicle-mediated heterogeneous communication between cancer and the lymphatic system facilitates lymphatic metastasis	6
Immunotherapy for multiple myeloma: new chances and hope	6
Organoid models in oncology: advancing precision cancer therapy and vaccine development	6
Recent advances in the systemic treatment of gastrointestinal stromal tumors	6
Nuclear PLD1 combined with NPM1 induces gemcitabine resistance through tumorigenic IL7R in pancreatic adenocarcinoma	6
Global, regional, and national burden of early-onset gastric cancer	6
Genomic medicine in clinical practice: national genomic medicine program in Japan	6
Hub genes associated with immune cell infiltration in breast cancer, identified through bioinformatic analyses of multiple datasets	6
Bispecific antibodies targeting immunomodulatory checkpoints for cancer therapy	6
Safety and efficacy of intraoperative radiation therapy using a low-energy X-ray source for resectable pancreatic cancer: an interim evaluation of an ongoing prospective phase II study	6
Accelerating the elimination of global cervical cancer through intelligent training for colposcopy	6
Plasma L-aspartic acid predicts the risk of gastric cancer and modifies the primary prevention effect: a multistage metabolomic profiling and Mendelian randomization study	5
Primary cilia in cancer: structures, functions, mechanisms, and therapeutic implications	5
Integrating artificial intelligence into radiological cancer imaging: from diagnosis and treatment response to prognosis	5
Evolving molecular subtyping of breast cancer advances precision treatment	5
Cervical cancer burden and trends in China, 2000–2020: Asia-Pacific international comparisons and insights for elimination goals	5
Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical tria	5
Bile acids, gut microbiota, and therapeutic insights in hepatocellular carcinoma	5
Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population	5
Peptide drugs: a new direction in cancer immunotherapy	5
Multifaceted efforts of governments, medical institutions, and financial organizations contribute to reducing the health inequality caused by economic differences	5
Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies	5
Global disparities in childhood neuroblastoma: trends, burden, and inequities from 1990 to 2021	5
Acetylated-PPARγ expression is regulated by different P53 genotypes associated with the adipogenic differentiation of polyploid giant cancer cells with daughter cells	5
National prevention programs and their effects on gastric cancer Incidence and mortality in East Asian countries	5
Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment	5
Potential new applications of immunotherapy for neuroendocrine neoplasms: immune landscape, current status and future perspectives	5
Detection and surveillance of circulating tumor cells in osteosarcoma for predicting therapy response and prognosis	5
From bone marrow to the tumor microenvironment: how neutrophil maturation shapes cancer immunity	5
Weight gain after 35 years of age is associated with increased breast cancer risk: findings from a large prospective cohort study	5
Mechanism and effects of extramedullary hematopoiesis on anti-tumor immunity	5
Impact of pre-neoadjuvant radioactive iodine seed marking on pathologic complete response and survival in early-stage breast cancer patients	4
Microbiome changes in esophageal cancer: implications for pathogenesis and prognosis	4
Inflammatory signaling in targeted therapy resistance: focus on EGFR-targeted treatment	4
XPO1 as a key regulator in small cell lung cancer: mechanisms, biomarkers, and therapeutic implications	4
Biomarkers for immune checkpoint inhibitors in colorectal cancer: recent advances and future perspectives	4
Impact of immunosuppressants on tumor pulmonary metastasis: new insight into transplantation for hepatocellular carcinoma	4
Exosomal miR-155 from gastric cancer induces cancer-associated cachexia by suppressing adipogenesis and promoting brown adipose differentiation via C/EPBβ	4
Esophageal cancer global burden profiles, trends, and contributors	4
SETD2 in cancer: functions, molecular mechanisms, and therapeutic regimens	4
Panoramic comparison between NK cells in healthy and cancerous liver through single-cell RNA sequencing	4
Rosiglitazone disrupts pancreatic ductal adenocarcinoma progression by activating the tumor suppressor ESE3/EHF	4
Lactate and lactylation in breast cancer: current understanding and therapeutic opportunities	4
CSCO guidelines for metastatic colorectal cancer: personalized medicine in clinical practice	4
Feasibility of sentinel lymph node biopsy omission after integration of 18F-FDG dedicated lymph node PET in early breast cancer: a prospective phase II trial	4
The interplay between RNA m<sup>6</sup>A modification and radiation biology of cancerous and non-cancerous tissues: a narrative review	4
Multi-omics in colorectal cancer liver metastasis: applications and research advances	4
Insight into the evolution of breast cancer driven by genetic alterations	4
Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004–2017: a population-based study	4
IL-33/ST2 signalling promotes tumor growth by regulating polarization of alternatively activated macrophages	4
Prospective study of the effect of ERAS on postoperative recovery and complications in patients with gastric cancer	4
Nanomedicine-based combination therapies for overcoming temozolomide resistance in glioblastomas	4
Cervical cancer prevention in China: where are we now, and what’s next?	3

Antibody-drug conjugates in breast cancer: advances and prospects	3
Genomic medicine and cancer clinical trial in Thailand	3
Retrospective analysis of disease characteristics and treatment patterns among patients with esophageal cancer across 14 surgically represented centers	3
Mechanisms underlying prostate cancer sensitivity to reactive oxygen species: overcoming radiotherapy resistance and recent clinical advances	3
The interplay between H3K36 methylation and DNA methylation in cancer	3
Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment	3
Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China	3
Evolution-driven crosstalk between glioblastoma and the tumor microenvironment	3
Natural killer cells in tumor immunotherapy	3
Carnitine palmitoyltransferase 1C promotes EMT-associated cisplatin resistance in non-small cell lung cancer cells	3
Comprehensive strategies for management of postoperative hyper-progression recurrence (HPR) of hepatocellular carcinoma: a 12-year large sample multi-center study	3
The outpost against cancer: universal cancer only markers	3
Influence of sex on outcomes of liver transplantation for hepatocellular carcinoma: a multicenter cohort study in China	3
Tumor-related fungi and crosstalk with gut fungi in the tumor microenvironment	3
Involvement of lncRNAs in the tumor microenvironment: a new property of tumor immunity	3
Innate IgM antibodies to mannose in patients with gastric cancer	3
Increased and persistent absolute CD4+ T cell count in an HIV-associated Burkitt lymphoma patient with central nervous system involvement after axicabtagene ciloleucel therapy	3
Emerging roles of plasmacytoid dendritic cell crosstalk in tumor immunity	3
DB-1310, a HER3-targeting antibody-drug conjugate, has synergistic anti-tumor activity with trastuzumab in HER2- and HER3-expressing breast cancer	3
IL-17A blockade alleviates immune checkpoint inhibitor-associated psoriasiform rash: preclinical and clinical responses	2
Mission of the National Cancer Center Hospital in Japan to promote clinical trials for precision medicine	2
Neutrophils in cancer: from immune defense to tumor promotion	2
Decreased LDHB expression in breast tumor cells causes NK cell activation and promotes tumor progression	2
Advances in gut microbiota-related treatment strategies for managing colorectal cancer in humans	2
Impact of government-organized screening programs on the economic burden of cervical cancer across five disease courses: a multistage regression and mediation analysis	2
Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer	2
Progress in clinical diagnosis and treatment of colorectal cancer with rare genetic variants	2
Revolutionizing tumor immunotherapy: unleashing the power of progenitor exhausted T cells	2
Current status of traditional Chinese medicine in modulating mitochondrial metabolic abnormalities in tumors	2
Hot issues in triple-negative breast cancer	2
Breast surgeons at the forefront: preserving lymph nodes for enhanced immunotherapy efficacy	2
Attitude towards genetic testing for breast cancer susceptibility genes and choice of prevention strategies in Chinese women with or without breast cancer	2
TNFSF15 facilitates the differentiation of CD11b+ myeloid cells into vascular pericytes in tumors	2
The mechanisms and clinical significance of CD8+ T cell exhaustion in anti-tumor immunity	2
The immune landscape of systemic inflammation in prostate cancer	2
Comprehensive investigation of the molecular basis of cancer dependencies suggests therapeutic options for breast cancer	2
Targeting mitochondrial dysfunction to intervene in liver cancer	2
Repurposing drugs for solid tumor treatment: focus on immune checkpoint inhibitors	2
MDM1 overexpression promotes p53 expression and cell apoptosis to enhance therapeutic sensitivity to chemoradiotherapy in patients with colorectal cancer	2
Epigenetic reprogramming in small cell lung cancer	2
Circulating cell-free mtDNA as a new biomarker for cancer detection and management	2
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration	2
Update on diffuse large B-cell lymphoma: highlights from the 2022 ASCO Annual Meeting	2
Prognostic value of peripheral eosinophil counts in patients with newly diagnosed multiple myeloma	2
A retrospective analysis of mature T- and NK-cell lymphomas	2
Target identification of natural products in cancer with chemical proteomics and artificial intelligence approaches	2
COX-2 inhibition synergizes with radioimmunotherapy by promoting TCF1+CD8+ T cell infiltration in NSCLC	2
Clinical management and survival outcomes of patients with different molecular subtypes of diffuse gliomas in China (2011–2017): a multicenter retrospective study from CGGA	2
The arginine metabolism battlefield: how metabolite exchange in the tumor microenvironment shapes an immunosuppressive ecosystem	2
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment: a prospective study of clinical functional MR-based modeling	2
Evaluation of an intelligent digital platform for population management in cervical cancer screening	2
Strengthening human papillomavirus vaccination programs through multi-country peer learning: lessons from the CHIC initiative	2
Combined chemo-endocrine therapy as a potential new option for HR+/HER2− advanced breast cancer: a prospective study of fulvestrant plus oral vinorelbine	2